K-numberK252428
Device nameElectric Wheelchair (Model P2)
ApplicantSuperpi Robot Co., Ltd.
Product codeITI
Device classClass II
Decision dateSep 18, 2025
DecisionSubstantially Equivalent
Regulation890.3860
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

The Electric Wheelchair Model P2 is a motor-driven, battery-operated, foldable powered wheelchair intended for indoor and outdoor use. It provides mobility to disabled or elderly persons limited to a seated position, featuring a brushless motor, electromagnetic brake system, rechargeable lithium-ion battery, and joystick control.

Technological characteristics

The subject device uses a brushless DC motor (24VDC, 250W, 2 units), automatic electromagnetic braking, 24 VDC 10Ah lithium-ion battery, and off-board charger. Minor differences from the predicate include slightly larger dimensions (37.80" vs 37"), higher total mass (57.3 lbs vs 35.3 lbs), different material for back cushion and seat cushion (PET vs polyester/fabric blends), and armrest material (ABS vs polyurethane). Performance parameters are comparable: max speed 6 km/h, max weight 300 lbs, maximum safe incline 10° vs 9°, and braking distance 0.9 m vs ≤1.5 m.

Test standards cited

ISO 7176 series (parts 1-15, 21-22, 25), ISO 16840-10:2021, ISO 10993-1 (biocompatibility), ISO 14971:2019 (risk analysis), IEC 60601-1-2:2020 (electromagnetic compatibility), and IEC 62133-2:2017 (battery testing).

Substantial equivalence argument

Both devices are Class II powered wheelchairs under 21 CFR 890.3860, comply with identical ISO standards, share the same intended use, design (rear-wheel drive with joystick control), and comparable safety/performance profiles. Minor dimensional, weight, and material differences do not raise new safety or effectiveness concerns because the device meets all applicable performance standards, demonstrates equivalent braking distance, stability, and obstacle-climbing capability, and uses biocompatible materials per ISO 10993-1. The predicate device has legally marketed substantial equivalence, and the subject device's nonclinical testing shows equivalent performance across all critical parameters.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →